Sponsored by:

Nuclear Medicine: Page 20

Lantheus posts healthy 2022 Q2 revenues
By AuntMinnie.com staff writers
Lantheus Medical Imaging parent company Lantheus Holdings reported a 121.4% increase in revenue in its 2022 second quarter, as well as net income compared to a net loss in 2021.
August 7, 2022
2017 08 16 13 40 50 749 Graph Arrow Up 400
Radiopharm collaborates with Lantheus on theranostic agent
By AuntMinnie.com staff writers
Radiopharm Theranostics has entered a collaboration agreement with Lantheus to develop NM-01, a nanobody that can be labeled with radioisotopes to diagnose and treat tumors for theranostic applications.
August 3, 2022
2021 07 12 17 41 2151 Business Men Handshake 400
Navidea highlights research on melanoma, oral cancer
By AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals is directing attention to new research from Australia on the use of its technetium-99m tilmanocept radiopharmaceutical in patients with melanoma or oral cancer.
August 1, 2022
2022 01 20 22 04 8815 Melanoma 400
What's the best way to get students interested in nuclear medicine?
By Brian Casey
What can be done to boost interest in nuclear medicine among medical students? Piquing their interest could be as simple as conducting a 30-minute seminar early in their medical training, according to a study published July 22 in Academic Radiology.
July 26, 2022
2021 03 19 23 20 5448 Doctors Medical Students Young 400
ITM selects Marx as chief business officer
By AuntMinnie.com staff writers
German radiopharmaceutical developer ITM Isotope Technologies Munich has named Sebastian Marx, PhD, as its chief business officer.
July 24, 2022
2020 04 22 17 11 4900 Business Handshake Man 400
NorthStar inks Ac-225 supply deal with Clovis
By AuntMinnie.com staff writers
NorthStar Medical Radioisotopes has signed a long-term supply agreement with Clovis Oncology for NorthStar's actinium-225 (Ac-225) therapeutic radioisotope.
July 20, 2022
2018 04 24 20 24 4264 Isotope 400
Clarity completes recruitment for prostate cancer trial
By AuntMinnie.com staff writers
Australian radiopharmaceutical developer Clarity Pharmaceuticals has completed recruitment for a PET study of its theranostic agent with copper-based radioisotopes for treating patients with prostate cancer.
July 19, 2022
2021 01 16 00 14 5464 Prostate Cancer 400
FDA clears Radialis PET imager
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has cleared Radialis' PET Imager, a small footprint, organ-targeted device.
July 17, 2022
2022 07 18 18 48 3323 2022 07 18 Radialis 400
FDA to allow Bayer to import contrast media
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) will now allow Bayer to import a limited quantity of iopromide, initially intended for international markets, for U.S. customers.
July 17, 2022
2019 12 19 17 46 9582 Bayer Rsna 2019 400
Nuclear medicine sentiment improves with expectations for higher volume
By Davin Korstjens
Nuclear medicine procedure volumes are expected to increase in 2022, but reimbursement, revenue, and net income are expected to stay the same, according to IMV Medical Information Division's newly published 2022 Nuclear Medicine Market Outlook Report.
July 7, 2022
2019 11 06 21 06 2992 Nuclear Medicine Gamma Camera 400
Mirion launches new brand for medical business units
By AuntMinnie.com staff writers
Mirion Technologies has launched a new brand called Mirion Medical that will now represent the company's Dosimetry Services, Sun Nuclear, CIRS, Biodex, and Capintec business units.
July 6, 2022
2021 12 02 20 51 1976 Mirion Rsna 2021 400
Jamaica gets first public nuclear medicine center
By AuntMinnie.com staff writers
Jamaica has opened the country's first public nuclear medicine center, at the University Hospital of the West Indies in Kingston, with a June 30 ceremony noting the support of the International Atomic Energy Agency.
July 5, 2022
2022 07 06 15 27 1089 Kingston Jamaica 400
Previous Page
Page 20 of 439
Next Page